It was further found that the reduction of Ebi3 expression level in C1q + cells can restore the anti-tumor killing ability of CD8+ T cells, while the loss of METTL14 expression can reduce the m6A modification level of Ebi3 mRNA in C1q + cells and promote the increase of its transcription level. This evidence concerns the gene EBI3 and neoplasm.